PHG / Philips ADRs Slide as FDA Says It's Unsatisfied With Sleep Apnea Machine Recall

Philips' (PHG) third-quarter results benefit from strong momentum across the Diagnosis & Treatment, Connected Care and Personal Health businesses. more_horizontal

American depositary receipts (ADRs) of Philips (PHG) advanced as the health technology firm posted better-than-expected results and raised its outlook more_horizontal

Dutch medical device maker Philips raised its 2023 earnings outlook on Monday after posting stronger third quarter sales and profits despite a recent more_horizontal

Philips CEO Roy Jakobs discusses the company's third-quarter results and the outlook for China. more_horizontal

Dutch health technology company Philips on Monday raised its full-year outlook as it beat analyst expectations with a more than doubling of third-quar more_horizontal

Koninklijke Philips' (PHG) third-quarter results are likely to reflect strength in the Diagnosis & Treatment and Connected Care segments amid macroeco more_horizontal

Philips (PHG) launches Visual Patient Avatar to help anesthesiologists with situational awareness in operating rooms, boosting their clinical confiden more_horizontal

Exor recently entered Philips with a 15% equity stake (and optionality to arrive at 20%). PHG agrees to conduct additional testing and notes ongoing c more_horizontal